These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32633461)

  • 1. LIX1 regulates YAP activity and controls gastrointestinal cancer cell plasticity.
    Guérin A; Martire D; Trenquier E; Lesluyes T; Sagnol S; Pratlong M; Lefebvre E; Chibon F; de Santa Barbara P; Faure S
    J Cell Mol Med; 2020 Aug; 24(16):9244-9254. PubMed ID: 32633461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LIX1 Controls MAPK Signaling Reactivation and Contributes to GIST-T1 Cell Resistance to Imatinib.
    Ruiz-Demoulin S; Trenquier E; Dekkar S; Deshayes S; Boisguérin P; Serrano C; de Santa Barbara P; Faure S
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LIX1 regulates YAP1 activity and controls the proliferation and differentiation of stomach mesenchymal progenitors.
    McKey J; Martire D; de Santa Barbara P; Faure S
    BMC Biol; 2016 Apr; 14():34. PubMed ID: 27125505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HAND1 and BARX1 Act as Transcriptional and Anatomic Determinants of Malignancy in Gastrointestinal Stromal Tumor.
    Hemming ML; Coy S; Lin JR; Andersen JL; Przybyl J; Mazzola E; Abdelhamid Ahmed AH; van de Rijn M; Sorger PK; Armstrong SA; Demetri GD; Santagata S
    Clin Cancer Res; 2021 Mar; 27(6):1706-1719. PubMed ID: 33451979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low ETV1 mRNA expression is associated with recurrence in gastrointestinal stromal tumors.
    Sakamaki K; Funasaka K; Miyahara R; Furukawa K; Yamamura T; Ohno E; Nakamura M; Kawashima H; Hirooka Y; Fujishiro M; Goto H
    Sci Rep; 2020 Sep; 10(1):14767. PubMed ID: 32901065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A smooth muscle-derived, Braf-driven mouse model of gastrointestinal stromal tumor (GIST): evidence for an alternative GIST cell-of-origin.
    Kondo J; Huh WJ; Franklin JL; Heinrich MC; Rubin BP; Coffey RJ
    J Pathol; 2020 Dec; 252(4):441-450. PubMed ID: 32944951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rs17084733 variant in the
    Ravegnini G; Serrano C; Simeon V; Sammarini G; Nannini M; Roversi E; Urbini M; Ferrè F; Ricci R; Tarantino G; Pantaleo MA; Hrelia P; Angelini S
    Epigenetics; 2019 Jun; 14(6):545-557. PubMed ID: 30983504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Expression of
    Yuan J; Kihara T; Kimura N; Hashikura Y; Ohkouchi M; Isozaki K; Takahashi T; Nishida T; Ito A; Hirota S
    Pathol Oncol Res; 2021; 27():602008. PubMed ID: 34257559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of low-density lipoprotein receptor class A domain containing 4 (LDLRAD4) as a prognostic indicator in primary gastrointestinal stromal tumors.
    Xie W; Xiao H; Luo J; Zhao L; Jin F; Ma J; Li J; Xiong K; Chen C; Wang G
    Curr Probl Cancer; 2020 Dec; 44(6):100593. PubMed ID: 32507364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression.
    Tang CM; Lee TE; Syed SA; Burgoyne AM; Leonard SY; Gao F; Chan JC; Shi E; Chmielecki J; Morosini D; Wang K; Ross JS; Kendrick ML; Bardsley MR; Siena M; Mao J; Harismendy O; Ordog T; Sicklick JK
    Oncotarget; 2016 Nov; 7(48):78226-78241. PubMed ID: 27793025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LIX1-mediated changes in mitochondrial metabolism control the fate of digestive mesenchyme-derived cells.
    Guérin A; Angebault C; Kinet S; Cazevieille C; Rojo M; Fauconnier J; Lacampagne A; Mourier A; Taylor N; de Santa Barbara P; Faure S
    Redox Biol; 2022 Oct; 56():102431. PubMed ID: 35988446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCAT6 mediates cellular biological functions in gastrointestinal stromal tumor via upregulation of PRDX5 and activation of Wnt pathway.
    Bai F; Zhang N; Fang W; He X; Zheng Y; Gu D
    Mol Carcinog; 2020 Jun; 59(6):661-669. PubMed ID: 32339330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin is a novel transcription regulator of KIT and is downregulated by miRNA-494 in gastrointestinal stromal tumors.
    Yun S; Kim WK; Kwon Y; Jang M; Bauer S; Kim H
    Int J Cancer; 2018 May; 142(10):2080-2093. PubMed ID: 29277888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of promyelocytic leukemia expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis.
    Ichikawa H; Yoshida A; Kanda T; Kosugi S; Ishikawa T; Hanyu T; Taguchi T; Sakumoto M; Katai H; Kawai A; Wakai T; Kondo T
    Cancer Sci; 2015 Jan; 106(1):115-24. PubMed ID: 25457157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of phenothiazine as an ETV1‑targeting agent in gastrointestinal stromal tumors using the Connectivity Map.
    Yen CC; Chen LT; Li CF; Chen SC; Chua WY; Lin YC; Yen CH; Chen YC; Yang MH; Chao Y; Fletcher JA
    Int J Oncol; 2019 Aug; 55(2):536-546. PubMed ID: 31268158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation.
    Kim WK; Park M; Kim YK; Tae YK; Yang HK; Lee JM; Kim H
    Clin Cancer Res; 2011 Dec; 17(24):7584-94. PubMed ID: 22042971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.
    Hayashi Y; Bardsley MR; Toyomasu Y; Milosavljevic S; Gajdos GB; Choi KM; Reid-Lombardo KM; Kendrick ML; Bingener-Casey J; Tang CM; Sicklick JK; Gibbons SJ; Farrugia G; Taguchi T; Gupta A; Rubin BP; Fletcher JA; Ramachandran A; Ordog T
    Gastroenterology; 2015 Aug; 149(2):420-32.e16. PubMed ID: 25865047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of FBXW7, a cell-cycle regulator, as a predictive marker of recurrence of gastrointestinal stromal tumors.
    Koga Y; Iwatsuki M; Yamashita K; Kiyozumi Y; Kurashige J; Masuda T; Eto K; Iwagami S; Harada K; Ishimoto T; Baba Y; Yoshida N; Miyanari N; Takamori H; Ajani JA; Baba H
    Gastric Cancer; 2019 Nov; 22(6):1100-1108. PubMed ID: 30854619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profiles of stemness genes in gastrointestinal stromal tumor.
    Bai C; Liu X; Xu J; Qiu C; Wang R; Zheng J
    Hum Pathol; 2018 Jun; 76():76-84. PubMed ID: 29486292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RACK1 overexpression is linked to acquired imatinib resistance in gastrointestinal stromal tumor.
    Gao X; Xue A; Fang Y; Shu P; Ling J; Hou Y; Shen K; Qin J; Sun Y; Qin X
    Oncotarget; 2016 Mar; 7(12):14300-9. PubMed ID: 26893362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.